Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.
Buse JB, Wolffenbuttel BH, Herman WH, Shemonsky NK, Jiang HH, Fahrbach JL, Scism-Bacon JL, Martin SA. Buse JB, et al. Among authors: scism bacon jl. Diabetes Care. 2009 Jun;32(6):1007-13. doi: 10.2337/dc08-2117. Epub 2009 Mar 31. Diabetes Care. 2009. PMID: 19336625 Free PMC article. Clinical Trial.
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF, Arakaki R, Jiang H, Scism-Bacon J, Anderson PW, Fahrbach JL. Miser WF, et al. Among authors: scism bacon j. Clin Ther. 2010 May;32(5):896-908. doi: 10.1016/j.clinthera.2010.05.001. Clin Ther. 2010. PMID: 20685497 Clinical Trial.
High-dose insulin therapy: is it time for U-500 insulin?
Lane WS, Cochran EK, Jackson JA, Scism-Bacon JL, Corey IB, Hirsch IB, Skyler JS. Lane WS, et al. Among authors: scism bacon jl. Endocr Pract. 2009 Jan-Feb;15(1):71-9. doi: 10.4158/EP.15.1.71. Endocr Pract. 2009. PMID: 19211405 Review.
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting.
Bergenstal RM, Garrison LP Jr, Wintle M, Blickensderfer A, Wade R, Hou L, Miller LA, Scism-Bacon J, Zagar A, Misurski D, Herman WH. Bergenstal RM, et al. Among authors: scism bacon j. Curr Med Res Opin. 2011 Mar;27(3):531-40. doi: 10.1185/03007995.2010.545814. Epub 2011 Jan 10. Curr Med Res Opin. 2011. PMID: 21219119
Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
Snyder PJ, Biller BM, Zagar A, Jackson I, Arafah BM, Nippoldt TB, Cook DM, Mooradian AD, Kwan A, Scism-Bacon J, Chipman JJ, Hartman ML. Snyder PJ, et al. Among authors: scism bacon j. J Bone Miner Res. 2007 May;22(5):762-70. doi: 10.1359/jbmr.070205. J Bone Miner Res. 2007. PMID: 17280527 Free article. Clinical Trial.
11 results